A clinical study demonstrated that ovarian cancer patients who had tumors with low levels of expression of caspase-8 had reduced survival rates, whereas patients with higher levels of caspase-8 had longer survival rates [52]. This evidence concerns the gene CASP8 and ovarian cancer.